Restoring Blood Flow. Restoring Life. Treating today’s atherosclerotic disease requires a new generation of tools for better outcomes. Learn More Opening Blocked Arteries Requires a New Approach An aging population and unhealthy lifestyles make atherosclerotic disease a leading health issue throughout the world. Learn More The Power of Serration Angioplasty Serration Technology is the next … Home Read More »
Employees: 11-50
Total raised: $41.87M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.02.2024 | Series C | $30M | - |
| 12.07.2018 | Series B | $11.87M | - |
Mentions in press and media 17
| Date | Title | Description |
| 08.05.2024 | Cagent Vascular names former Carl Zeiss Meditech exec as CEO | [Image courtesy of LinkedIn]Cagent Vascular announced this week that it has appointed Brian Walsh as CEO, effective immediately. Walsh has been chairing the company’s board of directors since March 2018 and will continue as chair. He will s... |
| 21.02.2024 | Cagent Vascular Raises $30M in Series C Financing | Cagent Vascular, a Wayne, PA-based commercial stage medical device company, raised $30M in Series C funding. The round was led by Venture Partners, with participation from new investors Blue Ridge Medical, and existing investors including S... |
| 21.02.2024 | Cagent Vascular sharpens up with $30M for serrated balloon catheter | In much the same way that Cagent Vascular’s flagship device is designed to help open up blocked arteries to promote blood flow, a recent round of funding for the startup is now slated to widen the device’s path in the commercial market. The... |
| 25.05.2022 | At an estimated value of over USD 4.02 billion in 2021, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 7.5% and valued at over USD 7.80 billion over the forecast year ... | New York, May 25, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Peripheral Artery Disease Market by Type, Global Opportunity Analysis and Industry Forecast, 2022 – 2030" - https://www.reportlinker.... |
| 12.07.2018 | Cagent Vascular Raises $11.87M in Series B Funding | Cagent Vascular, a Wayne, Pa.-based developer of angioplasty balloons using proprietary serration technology, completed an $11.87m in Series B funding. The round was led by two strategic investors including one that participated in the Seri... |
| 12.07.2018 | Cagent Vascular Raises $11.87M | WAYNE, Pa.--(BUSINESS WIRE)--Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, announced the completion of $11.87 million in Series B funding. The round was led by two strategic in... |
| 16.11.2017 | Ben Franklin Approved 4.4M in 25 Early Stage Companies | |
| 18.08.2016 | Ben Franklin Approved $2.9M for 13 Early Stage Companies | |
| 31.08.2012 | As peripheral artery disease innovations move forward, endoscopy stapler system raises $11M | Carol Burns, the co-founder and CEO of the Wayne, Pennsylvania-based company, said its system produces “less foreign material in the artery, less long-term chronic injury to the vessel and the ability to perform ‘spot’ treatment to the vess... |
| 28.02.2012 | Peripheral artery disease device company raises $2.5 million | Angioplasty is a procedure that uses balloons to widen narrowed or obstructed blood vessels. In the case of peripheral artery disease, the blood vessels can be located in the abdomen, legs or kidneys. Peripheral artery disease affects 8 mil... |
Show more